Branded Drug Prices Up Again (c/o Barclays)

As we’ve seen over the past few years, branded drug prices continue to go up YOY (year-over-year).  So far in 2011, based on analysis by Barclay’s Capital, the prices have gone up 7.2%.  You can see that this is the highest it’s been.

Given that brand drugs are typically only 20-30% of the oral solid market, this effect is dampened by the generic prices which typically go down.  At the same time, this can have a major impact on specialty drugs which are estimated to become about 40% of your spend by 2015.

2 Responses to “Branded Drug Prices Up Again (c/o Barclays)”

  1. Keep in mind that these are changes in list prices (WAC), not changes in the actual price paid by a consumer or third-party payer.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: